Prospective observational study to evaluate the usefulness of photon-counting CT in diagnosing resectability of pancreatic cancer after neoadjuvant treatment

Prospective observational study to evaluate the usefulness of photon-counting CT in diagnosing resectability of pancreatic cancer after neoadjuvant treatment - Phantom study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051860

Enrollment

Registered

2023-08-12

Start date

2023-05-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic adenocarcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All of the following (1)-(3) are met 1) Borderline resectable pancreatic cancer (BR) or locally advanced unresectable pancreatic cancer (UR-LA) with less than full circumference in contact with the relevant artery (ii) "Untreated with prior surgery, chemotherapy, or radiation therapy" or "Already underwent systemic chemotherapy or chemoradiotherapy, but photon-counting CT images are available before the start of treatment and when the decision for surgery was made" or "Undergoing systemic chemotherapy or chemoradiotherapy, but photon counting CT images are available before the start of treatment. (c) The patient has given written consent for this study.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Accuracy of diagnosis of resectability	—

Secondary

Measure	Time frame
Sensitivity, specificity, Positive Predictive Value, Negative Predictive Value, and AUC of ROC curve for the diagnosis of resectability	—

Countries

Japan

Contacts

Public ContactShinichiro Takahashi

Tokai University School of Medicine Department of Gastroenterological Surgery

shtakaha@tsc.u-tokai.ac.jp0463931121

Outcome results